US 11872225
Pyruvate kinase modulators and use thereof
granted A61KA61K31/5025A61K31/506
Quick answer
US patent 11872225 (Pyruvate kinase modulators and use thereof) held by Agios Pharmaceuticals, Inc. expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Agios Pharmaceuticals, Inc.
- Grant date
- Tue Jan 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/5025, A61K31/506, A61K31/519, A61K45/06